Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
15.27
+0.13 (0.86%)
Oct 10, 2025, 4:00 PM EDT - Market closed

Forte Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Cash & Equivalents
106.1422.2437.1341.142.0458.77
Upgrade
Short-Term Investments
-36.12----
Upgrade
Cash & Short-Term Investments
106.1458.3737.1341.142.0458.77
Upgrade
Cash Growth
333.28%57.21%-9.67%-2.25%-28.45%746.88%
Upgrade
Other Current Assets
1.472.981.20.410.481.13
Upgrade
Total Current Assets
107.6261.3538.3341.5142.5259.9
Upgrade
Net Property, Plant & Equipment
0.110.080.11--0.1
Upgrade
Other Long-Term Assets
0.060.140.540.490.791.24
Upgrade
Total Assets
107.7861.5638.984243.3161.24
Upgrade
Accounts Payable
5.34.881.421.150.951.24
Upgrade
Accrued Expenses
3.874.22.242.030.811.02
Upgrade
Total Current Liabilities
9.179.083.673.181.762.26
Upgrade
Total Liabilities
9.179.083.673.181.762.26
Upgrade
Common Stock
0.010.0100.020.020.01
Upgrade
Additional Paid-in Capital
279.5206.46153.83125.84114.7110.42
Upgrade
Accumulated Other Comprehensive Income
-0.010---
Upgrade
Retained Earnings
-180.9-154-118.52-87.04-73.17-51.46
Upgrade
Shareholders' Equity
98.6152.4835.3138.8241.5558.98
Upgrade
Total Liabilities & Equity
107.7861.5638.984243.3161.24
Upgrade
Net Cash (Debt)
106.1458.3737.1341.142.0458.77
Upgrade
Net Cash Growth
81.86%57.21%-9.67%-2.25%-28.45%746.88%
Upgrade
Net Cash Per Share
13.6420.0229.4059.1175.25199.64
Upgrade
Book Value
98.6152.4835.3138.8241.5558.98
Upgrade
Book Value Per Share
12.6818.0027.9655.8374.36200.37
Upgrade
Tangible Book Value
98.6152.4835.3138.8241.5558.98
Upgrade
Tangible Book Value Per Share
12.6818.0027.9655.8374.36200.37
Upgrade
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q